Community Health Syst. Inc.

At the annual meeting, Community Health Systems shareholders elected 14 directors for terms running through 2027 and approved executive compensation in a non-binding advisory vote. They also confirmed Deloitte & Touche LLP as the independent auditor for the fiscal year ending December 31, 2026. The company reported weaker Q1 results (EPS of -$0.43 vs. -$0.10 expected) on slightly better revenue and accepted bonds totaling about $599 million under a tender offer. » Więcej na de.investing.com

Community Health Systems reported Q1 2026 earnings per share of -$0.43, missing the expectation of -$0.10 by a wide margin. Revenue was $2.97 billion, slightly above forecasts, but adjusted EBITDA fell to $309 million and operating cash flow deteriorated to -$297 million. The company continues to pursue strategic investments in ambulatory surgery centers. After the results were released, the stock fell about 6.8% in premarket trading. » Więcej na de.investing.com

Truist Securities cut its price target for Community Health Systems to $3.50 from $4.00 while keeping a Hold rating as part of a broader healthcare services update that noted generally positive industry conditions. Community Health Systems finalized the sale of Crestwood Medical Center and related outpatient assets to Huntsville Hospital Health System for $459 million, part of a portfolio-streamlining strategy. Truist highlighted supportive reimbursement trends, strong cash generation and sector defensive qualities that underpin continued investment and shareholder returns. » Więcej na finance.yahoo.com